1-5 of 5
Benjamin S. Hoffman
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 2172: ON 123300, an orally administered novel CDK4/6 + ARK5 inhibitor, exhibits potent antitumor activity in vivo: comparative studies with Palbociclib

Shraddha Patel, Priya Pancholi, Tanvi Visal, Amruta Samant, Dhvanir Kansara, V J. Rajadhyaksha, Benjamin S. Hoffman, Manoj Maniar, Vikas Sehdev
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 2172.
https://doi.org/10.1158/1538-7445.AM2017-2172
Published: 01 July 2017
View article titled, Abstract 2172: ON 123300, an orally administered novel CDK4/6 + ARK5 inhibitor, exhibits potent antitumor activity in vivo: comparative studies with Palbociclib
Journal Articles

Abstract 4687: Rigosertib synergistically enhances the anticancer activity of Cisplatin in various preclinical models of upper gastrointestinal cancers

Priya Pancholi, Tanmay Dichwalkar, Samhita Bapat, V. J. Rajadhyaksha, Benjamin S. Hoffman, Manoj Maniar, Vikas Sehdev
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 4687.
https://doi.org/10.1158/1538-7445.AM2016-4687
Published: 15 July 2016
View article titled, Abstract 4687: Rigosertib synergistically enhances the anticancer activity of Cisplatin in various preclinical models of upper gastrointestinal cancers
Journal Articles

Abstract 1649: Potent anticancer activity of an orally bioavailable small molecule, ON 013100, and its water soluble derivative, briciclib, a clinical-stage eIF4E-targeted agent

Neel Jasani, Bina Desai, Justine M. Betzu, Tanmay Dichwalkar, Samhita Bapat, V. J. Rajadhayksha, Benjamin S. Hoffman, Manoj Maniar, Vikas Sehdev
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 1649.
https://doi.org/10.1158/1538-7445.AM2015-1649
Published: 01 August 2015
View article titled, Abstract 1649: Potent anticancer activity of an orally bioavailable small molecule, ON 013100, and its water soluble derivative, briciclib, a clinical-stage eIF4E-targeted agent
Journal Articles

Abstract 4524: ON015640, a novel anti-cancer agent with tubulin depolymerizing activity

Benjamin S. Hoffman, Stephen C. Cosenza, Venkat Palella, Ramana Reddy, EP Reddy
Journal: Cancer Research
Cancer Res (2011) 71 (8_Supplement): 4524.
https://doi.org/10.1158/1538-7445.AM2011-4524
Published: 15 April 2011
View article titled, Abstract 4524: ON015640, a novel anti-cancer agent with tubulin depolymerizing activity
Journal Articles

Intravesical Immunotherapy of Superficial Bladder Cancer with Chitosan/Interleukin-12

David A. Zaharoff, Benjamin S. Hoffman, H. Brooks Hooper, Compton J. Benjamin, Jr., Kiranpreet K. Khurana, Kenneth W. Hance, Connie J. Rogers, Peter A. Pinto, Jeffrey Schlom, John W. Greiner
Journal: Cancer Research
Cancer Res (2009) 69 (15): 6192–6199.
https://doi.org/10.1158/0008-5472.CAN-09-1114
Published: 29 July 2009
View article titled, Intravesical Immunotherapy of Superficial Bladder Cancer with Chitosan/Interleukin-12
Open the PDF for Intravesical Immunotherapy of Superficial Bladder Cancer with Chitosan/Interleukin-12 in another window
Includes: Supplementary data